Literature DB >> 888785

Muscle protein catabolism in the septic patient as measured by 3-methylhistidine excretion.

C L Long, W R Schiller, W S Blakemore, J W Geiger, M O'Dell, K Henderson.   

Abstract

Muscle protein catabolism has been evaluated using the excretion of urinary 3-methylhistidine (3-MEH) is six normal male and six normal female subjects and in four surgical patients, two of whom developed febrile episodes during the course of their study. In addition, their nutritional status was also evaluated using percentage body weight losses before hospital admittance, creatinine-height ratios, and, in two patients, serum alkaline ribonuclease levels. The results indicate that: 1) prolonged starvation may produced decreased 3-MEH excretion because of an adaptive diminution of muscle breakdown in sustained starvation, decreased 3-MEH excretion also may simply reflect diminished lean body mass, 3-MEH excretion may be increased above basal levels because of superimposed stresses such as fever, and the acute phases of starvation produce increased levels of 3-MEH excretion until adaptive mechanisms occur; 2) creatinine-height ratios are low in starvation, and increase not only with improved nutrition but in response to fever and stress of operation, even when these are superimposed on malnutrition; and 3) alkaline RNAase levels are elevated in malnutrition and decrease with improved nutrition but in response to fever and stress of operation, even when these are superimposed on malnutrition; and 3) alkaline RNAase levels are elevated in malnutrition and decrease with improved nutrition. The enzyme may also be elevated by the stress of operations.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 888785     DOI: 10.1093/ajcn/30.8.1349

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  12 in total

Review 1.  Monitoring the nutritional status of critically ill patients.

Authors:  A Shenkin
Journal:  Intensive Care Med       Date:  1979-11       Impact factor: 17.440

2.  Current issues and priorities in childhood nutrition, growth, and infections.

Authors:  Rehana A Salam; Jai K Das; Zulfiqar A Bhutta
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

3.  Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown.

Authors:  M Elia; A Carter; S Bacon; C G Winearls; R Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-31

4.  The metabolic effects of moderately severe upper gastrointestinal haemorrhage in man.

Authors:  K J Foster; K G Alberti; C Binder; G Holdstock; S J Karran; C L Smith; S Talbot; D C Turnell
Journal:  Postgrad Med J       Date:  1982-01       Impact factor: 2.401

5.  Resting energy expenditure in controls and cancer patients with localized and diffuse disease.

Authors:  J M Arbeit; D E Lees; R Corsey; M F Brennan
Journal:  Ann Surg       Date:  1984-03       Impact factor: 12.969

6.  Time course changes in blood metabolites during endotoxin fever in sheep.

Authors:  B G Southorn; J R Thompson
Journal:  Can J Vet Res       Date:  1986-07       Impact factor: 1.310

7.  Endogenous 3-methylhistidine excretion in healthy women and men with reference to muscle protein metabolism.

Authors:  M Neuhäuser; K H Bässler
Journal:  Z Ernahrungswiss       Date:  1984-09

8.  Whole-body protein breakdown and 3-methylhistidine excretion during brief fasting, starvation, and intravenous repletion in man.

Authors:  S F Lowry; G D Horowitz; M Jeevanandam; A Legaspi; M F Brennan
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

9.  Stimulation of protein synthesis and breakdown by vaccination.

Authors:  P J Garlick; M A McNurlan; E B Fern; A M Tomkins; J C Waterlow
Journal:  Br Med J       Date:  1980-07-26

10.  Survival from sepsis. The significance of altered protein metabolism regulated by proteolysis inducing factor, the circulating cleavage product of interleukin-1.

Authors:  G H Clowes; E Hirsch; B C George; L M Bigatello; J E Mazuski; C A Villee
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.